Tardive Dyskinesia Therapeutics Market Gains Momentum Through Improved Diagnostic Awareness
The global Tardive Dyskinesia Therapeutics Market is gaining significant momentum as healthcare providers increasingly focus on addressing the long-term neurological complications associated with antipsychotic medications. According to Polaris Market Research, the market was valued at USD 3.83 billion in 2023 and is projected to reach USD 5.57 billion by 2032, expanding at a CAGR of 4.3% during...
0 Comments 0 Shares 15 Views 0 Reviews